VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
← Pulse/Companies

BlossomHill on Pulse

Biotech

The full thread of our BlossomHill coverage — a running record of every development we've tracked, with the VC take on each.

2
Stories
2
With a headline figure
Aug 8, 2026
Since

Coverage Timeline

newest first
  1. Aug 10, 2026IPOBiotech IPO Window Closes Its Strongest Week Since Spring~$972M, 4 deals→
  2. Aug 8, 2026IPOBiotech IPOs Are Pricing Above Range Again$532.5M combined→

All Coverage

IPO· Aug 10, 2026

Biotech IPO Window Closes Its Strongest Week Since Spring

Illustration for: Biotech IPO Window Closes Its Strongest Week Since Spring
IPO~$972M, 4 deals

Biotech IPO Window Closes Its Strongest Week Since Spring

BlossomHill and Latigo Biotherapeutics both closed upsized IPOs by August 10, capping a four-deal stretch that also included Braveheart Bio and Attovia Therapeutics pricing above or near the top of their ranges.

Aug 10, 2026FOLLOW-UP
IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

Aug 8, 2026BY THE NUMBERS
@Trace_Cohen·t@nyvp.com